Article Text
Abstract
The posterior reversible encephalopathy syndrome is an increasingly recognised disorder. Most patients have several symptoms; seizures are the most frequent, often multiple or status epilepticus. A combination of seizures, visual disturbance and/or headache, in particular, should lead to an early brain MRI to reveal the typical pattern of bilateral hyperintensities on fluid attenuated inversion recovery imaging, predominantly in the parieto-occipital region. There seem to be many possible triggers, including abrupt arterial hypertension, impaired renal function, pregnancy, immunosuppressive therapies and various inflammatory conditions. The clinical outcome is excellent, with recovery within a few days, while the MRI abnormalities resolve much more slowly. Little is known about the best management. Seizures do not normally progress to chronic epilepsy so antiepileptic drugs should be discontinued after about 3 months.
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Provenance and peer review Commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Posterior reversible encephalopathy syndrome (PRES): diagnosis and management
- Cerebral-autoregulatory dysfunction syndrome
- Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
- Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment
- Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement
- An unusual cause of altered mental status: the importance of monitoring a patient's blood pressure
- Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion
- Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine
- Posterior reversible encephalopathy syndrome: long-term follow-up
- Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage